Tasigna International Website 
For Healthcare Professionals Outside the U.S.
U.S. Residents| Change Language
 
  • larger text larger text   
  • E-mail this page
  • print this page print this page
Back to Web Page  |  Print This Page
The Power of Precision against Ph+ CML
Clinical Trials
Recent Publications
View citations and access online abstracts of latest Ph+ CML-related research. view recent publications
Clinical Trials
For Your Patients
Help your patients have a good start with Tasigna. Use these educational materials to help your patients understand Tasigna and their disease.

learn more
For Your Patients
   
Prescribing Information
Stay Informed
Get updates on clinical data, Ph+ CML news and upcoming events.   Register now


This is an international website for Tasigna (nilotinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click here. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

Home | About Tasigna | Ph + CML Information | For Your Patients | News & Events | Resources | Product Information
About Novartis Oncology | Privacy Information | Site Map | Contact Us

Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG